SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Birgegård Andreas) "

Sökning: WFRF:(Birgegård Andreas)

  • Resultat 1-10 av 51
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Schaumberg, Katherine, et al. (författare)
  • Patterns of diagnostic transition in eating disorders : a longitudinal population study in Sweden
  • 2019
  • Ingår i: Psychological Medicine. - : Cambridge University Press. - 0033-2917 .- 1469-8978. ; 49:5, s. 819-827
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Transition across eating disorder diagnoses is common, reflecting instability of specific eating disorder presentations. Previous studies have examined temporal stability of diagnoses in adult treatment-seeking samples but have not uniformly captured initial presentation for treatment. The current study examines transitions across eating disorder diagnostic categories in a large, treatment-seeking sample of individuals born in Sweden and compares these transitions across two birth cohorts and from initial diagnosis.METHODS: Data from Swedish eating disorders quality registers were extracted in 2013, including 9622 individuals who were seen at least twice from 1999 to 2013. Patterns of remission were examined in the entire sample and subsequently compared across initial diagnoses. An older (born prior to 1990) and younger birth cohort were also identified, and analyses compared these cohorts on patterns of diagnostic transition.RESULTS: Although diagnostic instability was common, transition between threshold eating disorder diagnoses was infrequent. For all diagnoses, transition to remission was likely to occur following a diagnosis state that matched initial diagnosis, or through a subthreshold diagnostic state. Individuals in the younger cohort were more likely to transition to a state of remission than those in the older cohort.CONCLUSIONS: Results indicate more temporal continuity in eating disorder presentations than suggested by previous research and highlight the importance of early detection and intervention in achieving remission.
  •  
2.
  • Andersén, Mikael, 1985-, et al. (författare)
  • Diagnosis‐specific self‐image predicts longitudinal suicidal ideation in adult eating disorders
  • 2017
  • Ingår i: International Journal of Eating Disorders. - : John Wiley & Sons. - 0276-3478 .- 1098-108X. ; 50:8, s. 970-978
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Eating disorders (ED) are prevalent, serious illnesses with elevated mortality, mainly attributable to suicide. Predictors of suicidality include binge/purge symptomatology, impulsivity, and psychiatric comorbidity, as well as personality factors. Recent research has also shown self‐image (the Structural Analysis of Social Behavior, SASB, model) to predict manifest suicide attempts in ED, and the study explored suicide risk prediction to increase knowledge of warning signs and intervention targets.Method: Participants were adult ED patients registered in the Stepwise clinical database (N = 1537) with anorexia nervosa (AN), bulimia nervosa (BN), binge‐eating disorder (BED), or other specified feeding and eating disorder (OSFED). The SASB self‐image questionnaire was used in stepwise regressions to predict 12‐month suicidal ideation, both self‐ and clinician‐rated, in models both excluding and including baseline clinical variables.Results: Validation analyses showed fair correspondence between outcome variables as well as with suicide attempts. Different variables predicted suicidality in different diagnoses, over and above baseline clinical variables in all but one regression model. Low Self‐protection was important in AN and BN, high Self‐control in AN, and high Letting go of the self in BN. For BED, self‐blame explained variance, and in OSFED, lack of self‐love.Discussion: Findings are in line with research showing differential self‐image‐based prediction of important outcomes in ED, with noteworthy consistencies across diagnoses and suicidality variables. Strengths included the large sample, and limitations pertained to measures, attrition and Type II error risk. Replication is needed, but findings are consistent with some previous work and offers clinical and research implications.
  •  
3.
  • Barbui, Tiziano, et al. (författare)
  • Philadelphia-Negative Classical Myeloproliferative Neoplasms : Critical Concepts and Management Recommendations From European LeukemiaNet
  • 2011
  • Ingår i: Journal of Clinical Oncology. - 0732-183X .- 1527-7755. ; 29:6, s. 761-770
  • Tidskriftsartikel (refereegranskat)abstract
    • We present a review of critical concepts and produce recommendations on the management of Philadelphia-negative classical myeloproliferative neoplasms, including monitoring, response definition, first-and second-line therapy, and therapy for special issues. Key questions were selected according the criterion of clinical relevance. Statements were produced using a Delphi process, and two consensus conferences involving a panel of 21 experts appointed by the European LeukemiaNet (ELN) were convened. Patients with polycythemia vera (PV) and essential thrombocythemia (ET) should be defined as high risk if age is greater than 60 years or there is a history of previous thrombosis. Risk stratification in primary myelofibrosis (PMF) should start with the International Prognostic Scoring System (IPSS) for newly diagnosed patients and dynamic IPSS for patients being seen during their disease course, with the addition of cytogenetics evaluation and transfusion status. High-risk patients with PV should be managed with phlebotomy, low-dose aspirin, and cytoreduction, with either hydroxyurea or interferon at any age. High-risk patients with ET should be managed with cytoreduction, using hydroxyurea at any age. Monitoring response in PV and ET should use the ELN clinicohematologic criteria. Corticosteroids, androgens, erythropoiesis-stimulating agents, and immunomodulators are recommended to treat anemia of PMF, whereas hydroxyurea is the first-line treatment of PMF-associated splenomegaly. Indications for splenectomy include symptomatic portal hypertension, drug-refractory painful splenomegaly, and frequent RBC transfusions. The risk of allogeneic stem-cell transplantation-related complications is justified in transplantation-eligible patients whose median survival time is expected to be less than 5 years.
  •  
4.
  • Barbuil, Tiziano, et al. (författare)
  • Philadelphia chromosome-negative classical myeloproliferative neoplasms : revised management recommendations from European LeukemiaNet
  • 2018
  • Ingår i: Leukemia. - : Nature Publishing Group. - 0887-6924 .- 1476-5551. ; 32:5, s. 1057-1069
  • Forskningsöversikt (refereegranskat)abstract
    • This document updates the recommendations on the management of Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-neg MPNs) published in 2011 by the European LeukemiaNet (ELN) consortium. Recommendations were produced by multiple-step formalized procedures of group discussion. A critical appraisal of evidence by using Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methodology was performed in the areas where at least one randomized clinical trial was published. Seven randomized controlled trials provided the evidence base; earlier phase trials also informed recommendation development. Key differences from the 2011 diagnostic recommendations included: lower threshold values for hemoglobin and hematocrit and bone marrow examination for diagnosis of polycythemia vera (PV), according to the revised WHO criteria; the search for complementary clonal markers, such as ASXL1, EZH2, IDH1/IDH2, and SRSF2 for the diagnosis of myelofibrosis (MF) in patients who test negative for JAK2V617, CALR or MPL driver mutations. Regarding key differences of therapy recommendations, both recombinant interferon alpha and the JAK1/JAK2 inhibitor ruxolitinib are recommended as second-line therapies for PV patients who are intolerant or have inadequate response to hydroxyurea. Ruxolitinib is recommended as first-line approach for MF-associated splenomegaly in patients with intermediate-2 or high-risk disease; in case of intermediate-1 disease, ruxolitinib is recommended in highly symptomatic splenomegaly. Allogeneic stem cell transplantation is recommended for transplant-eligible MF patients with high or intermediate-2 risk score. Allogeneic stem cell transplantation is also recommended for transplant-eligible MF patients with intermediate-1 risk score who present with either refractory, transfusion-dependent anemia, blasts in peripheral blood > 2%, adverse cytogenetics, or high-risk mutations. In these situations, the transplant procedure should be performed in a controlled setting.
  •  
5.
  •  
6.
  • Birgegård, Andreas, et al. (författare)
  • Anorexic self-control and bulimic self-hate : differential outcome prediction from initial self-image
  • 2009
  • Ingår i: International Journal of Eating Disorders. - : Wiley. - 0276-3478 .- 1098-108X. ; 42:6, s. 522-530
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE:: The study investigated initial self-image (structural analysis of social behavior) and its relation to 36-month outcome, among patients with anorexia nervosa and bulimia nervosa. Hypotheses were that degree of different aspects of self-image would predict outcome in the groups. METHOD:: Participants were 52 patients with anorexia and 91 with bulimia from a longitudinal naturalistic database, and outcome measures included eating disorder and psychiatric symptoms and a general outcome index. Stepwise regression was used to investigate which self-image variables were related to outcome, and multiple regression contrasted the groups directly on each obtained predictor. RESULTS:: Consistent with hypotheses, in bulimia degree of self-hate/self-love moderately predicted outcome, whereas self-control-related variables powerfully predicted outcome in anorexia. CONCLUSION:: It is important to focus on self-image in the treatment of both diagnostic groups, but especially in anorexia nervosa, where control-submission interactions between patient and therapist should be handled with care.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Birgegård, Andreas, et al. (författare)
  • New methodological advice for research in subliminal psychodynamic activation
  • 1999
  • Ingår i: Perceptual and Motor Skills. - 0031-5125 .- 1558-688X. ; 88:3, s. 747-755
  • Tidskriftsartikel (refereegranskat)abstract
    • Recent integration among approaches to perception without awareness has brought the usefulness of Subliminal Psychodynamic Activation into renewed locus. Several authors have discussed the possible detrimental impact on interpretation when control phrase
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 51
Typ av publikation
tidskriftsartikel (43)
annan publikation (3)
konferensbidrag (2)
doktorsavhandling (2)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (42)
övrigt vetenskapligt/konstnärligt (6)
populärvet., debatt m.m. (3)
Författare/redaktör
Birgegård, Andreas (41)
Clinton, David (11)
Norring, Claes (10)
Björck, Caroline (10)
Kiladjian, Jean-Jacq ... (9)
Cervantes, Francisco (9)
visa fler...
Passamonti, Francesc ... (9)
Vannucchi, Alessandr ... (9)
Reiter, Andreas (9)
Monell, Elin (9)
Griesshammer, Martin (8)
Barosi, Giovanni (8)
Sohlberg, Staffan (8)
Forsén Mantilla, Emm ... (8)
Bulik, Cynthia M. (8)
Birgegård, Gunnar (7)
Andreasson, Bjorn (7)
Harrison, Claire N. (7)
Samuelsson, Jan (6)
Larsson, Henrik, 197 ... (6)
Barbui, Tiziano (6)
Zweegman, Sonja (6)
Thornton, Laura M. (6)
Cahn, Jean-Yves (6)
Besses, Carlos (6)
Rambaldi, Alessandro (6)
Dueck, Amylou C. (6)
Stegelmann, Frank (6)
Lehmann, Thomas (6)
Bonatz, Karin (6)
Boyer, Francoise (6)
Etienne, Gabriel (6)
Ranta, Dana (6)
Roy, Lydia (6)
Xiao, Zhijian (6)
Mesa, Ruben A. (6)
Lichtenstein, Paul (5)
Almqvist, Catarina (5)
Ianotto, Jean Christ ... (5)
Zhang, Yue (5)
Tefferi, Ayalew (5)
Schouten, Harry C. (5)
Slot, Stefanie (5)
Sackmann, Federico (5)
Kerguelen Fuentes, A ... (5)
Pahl, Heike L. (5)
Sun, Xiujuan (5)
Xu, Junqing (5)
Zhang, Peihong (5)
Hernández-Maraver, D ... (5)
visa färre...
Lärosäte
Karolinska Institutet (35)
Uppsala universitet (27)
Örebro universitet (10)
Högskolan i Gävle (8)
Gymnastik- och idrottshögskolan (8)
Umeå universitet (6)
visa fler...
Linköpings universitet (4)
Lunds universitet (2)
Linnéuniversitetet (2)
Marie Cederschiöld högskola (2)
Göteborgs universitet (1)
visa färre...
Språk
Engelska (45)
Svenska (5)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (33)
Samhällsvetenskap (12)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy